Associated Papers
Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling.
Kaufmann M et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2021
The Impact of CYP24A1 Polymorphisms on Hypertension Susceptibility.
Bao Q et al.
Kidney & Blood Pressure Research, 2020
25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D.
Jones G et al.
Archives of Biochemistry and Biophysics, 2012
Bioengineering anabolic vitamin D-25-hydroxylase activity into the human vitamin D catabolic enzyme, cytochrome P450 CYP24A1, by a V391L mutation.
Kaufmann M et al.
The Journal of Biological Chemistry, 2011
Mutations in CYP24A1 and idiopathic infantile hypercalcemia.
Schlingmann KP et al.
The New England Journal of Medicine, 2011
Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D3-26,23-lactone.
Prosser DE et al.
Proceedings of the National Academy of Sciences of the United States of America, 2007
Select a paper to view details